News Overview

Wipro has granted 12453 restricted stock units under the companys ADS restricted stock unit plan The grant is effective from 24 March 2022

SJVN announced the cessation of Subhash Chander Negi DIN 01830394 and Dr Rajnish Pande DIN 08406125 as directors of the company on completion of their tenure of appointment of 25 March 2022

Parsharti Investment will hold a meeting of the Board of Directors of the Company on 30 March 2022

Union Bank of India has been allotted 119695455 shares of Rs 10 each through preferential allotment by National Asset Reconstruction Company NARCL on 23 March 2022 The allotment translates into an equity shareholding of 990Percentage of the total paid up share capital of NARCL

Haldyn Glass will hold a meeting of the Board of Directors of the Company on 28 March 2022

Orchid Pharma has incorporated a Wholly Owned Subsidiary in India namely Orchid Bio-Pharma on 24 March 2022 The incorporation of the Wholly owned subsidiary will leverage the growth opportunities in the evolving Pharma space

Supreme Holdings Hospitality will hold a meeting of the Board of Directors of the Company on 29 March 2022

Capri Global Capital announced that its wholly owned subsidiary Capri Global Housing has entered into a co-lending alliance for housing loans with the State Bank of India The co-lending framework will collaborate the operational management expertise of Capri Global Housing and low-cost fund of State Bank of India to offer affordable credit solution to the borrowers The loan disbursement under this arrangement will commence from […]

Bharti Airtel today said that it has paid Rs 8815 crore to the Department of Telecom Government of India towards part prepayment of deferred liabilities pertaining to spectrum acquired in auction of year 2015 The prepayment is for instalments due in FY 2027 and FY 2028 Over the last four months Airtel has cleared Rs 24334 crore of its deferred spectrum liabilities much ahead of […]

Sun Pharmaceuticals Industries announced that the Companys wholly owned US subsidiary presented data from two pivotal Phase 3 clinical trials of WINLEVI clascoterone cream 1Percentage for the topical treatment of acne vulgaris acne The results which showed favorable safety and efficacy data in patients 12 years of age and older with acne were reported today in a poster podium presentation at the American Academy of […]